Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Sucralfate and Helicobacter pylori

A Terano¹, T Shimada, H Hiraishi

¹Second Department of Medicine, Dokkyo University, School of Medicine, Tochigi, Japan.

Journal of Gastroenterology

|November 1, 1996

Summary

Sucralfate boosts Helicobacter pylori eradication with antibiotics by acting on mucus gel. Further research is needed to fully understand its anti-ulcer mechanisms beyond H. pylori eradication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.

Alimentary pharmacology & therapeutics·2013

Same author

Data compression of the kanji character patterns digitized on the hexagonal mesh.

IEEE transactions on pattern analysis and machine intelligence·2011

Same author

Percutaneous ethanol injection therapy for hepatocellular-carcinoma (review).

International journal of oncology·2011

Same author

Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection--the results of a multicentre, double-blind, randomized clinical trial (IMPACT study).

Alimentary pharmacology & therapeutics·2010

Same author

Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer.

British journal of cancer·2008

Same author

Education and imaging. Hepatobiliary and pancreatic: arteriovenous malformation of the pancreas.

Journal of gastroenterology and hepatology·2008

Area of Science:

Gastroenterology
Pharmacology
Microbiology

Background:

Helicobacter pylori (H. pylori) infection is a major cause of peptic ulcer disease.
Sucralfate is an established anti-ulcer medication with a known cytoprotective effect.
The precise anti-ulcer mechanism of sucralfate, particularly its relationship with H. pylori eradication, remains incompletely understood.

Purpose of the Study:

To investigate the role of sucralfate in enhancing the eradication of H. pylori.
To explore the mechanisms by which sucralfate exerts its effects on H. pylori.
To clarify whether sucralfate's anti-ulcer actions are primarily mediated by H. pylori eradication.

Main Methods:

Administration of sucralfate in conjunction with standard antibiotic therapy for H. pylori.
Analysis of H. pylori eradication rates in patients receiving sucralfate plus antibiotics versus antibiotics alone.
In vitro or in vivo studies examining sucralfate's interaction with H. pylori and the gastric mucus layer.

Main Results:

Sucralfate significantly enhanced the eradication rate of H. pylori when used with antibiotics.
Evidence suggests sucralfate's action against H. pylori involves interaction with the mucus gel.
The contribution of H. pylori eradication to sucralfate's overall anti-ulcer efficacy is still debated.

Conclusions:

Sucralfate is a valuable adjunct to antibiotic therapy for improving H. pylori eradication rates.
Sucralfate possesses direct or indirect anti-H. pylori activity, potentially mediated through the gastric mucus.
Further investigation into sucralfate's multifaceted mechanisms of action is warranted, given its efficacy, tolerability, and cost-effectiveness as an anti-ulcer agent.

Related Experiment Videos